Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q88124206 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235817.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q88124206 | ||
| 024 | ‡a 0000-0003-2072-4826 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q88124206 | ||
| 100 | 0 | ‡a Liguo Wang ‡c researcher (ORCID 0000-0003-2072-4826) ‡9 en | |
| 400 | 0 | ‡a Liguo Wang ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer | ||
| 670 | ‡a Author's CircularLogo: A lightweight web application to visualize intra-motif dependencies. | ||
| 670 | ‡a Author's HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer | ||
| 670 | ‡a Author's Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. | ||
| 670 | ‡a Author's MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation | ||
| 670 | ‡a Author's SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition | ||
| 909 | ‡a (orcid) 0000000320724826 ‡9 1 | ||
| 919 | ‡a ailanthonetargetsp23toovercomemdv3100resistanceincastrationresistantprostatecancer ‡A Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer ‡9 1 | ||
| 919 | ‡a spopmutationinducesreplicationoverfiringbyimpairinggemininubiquitinationandtriggersreplicationcatastropheuponatrinhibition ‡A SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition ‡9 1 | ||
| 919 | ‡a magetrim28complexpromotesthewarburgeffectandhepatocellularcarcinomaprogressionbytargetingfbp1fordegradation ‡A MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation ‡9 1 | ||
| 919 | ‡a intrinsicbetinhibitorresistanceinspopmutatedprostatecancerismediatedbybetproteinstabilizationandaktmtorc1activation ‡A Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. ‡9 1 | ||
| 919 | ‡a hdac5lossimpairsrbrepressionofprooncogenicgenesandconferscdk46inhibitorresistanceincancer ‡A HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer ‡9 1 | ||
| 919 | ‡a circularlogoalightweightwebapplicationtovisualizeintramotifdependencies ‡A CircularLogo: A lightweight web application to visualize intra-motif dependencies. ‡9 1 | ||
| 996 | ‡2 RERO|A003957507 | ||
| 996 | ‡2 NSK|000337340 | ||
| 996 | ‡2 NSK|000754545 | ||
| 996 | ‡2 PTBNP|41206 | ||
| 996 | ‡2 SUDOC|162018053 | ||
| 996 | ‡2 NUKAT|n 2014061020 | ||
| 996 | ‡2 LC|n 85064938 | ||
| 996 | ‡2 ISNI|0000000088934078 | ||
| 996 | ‡2 CAOONL|ncf11889708 | ||
| 996 | ‡2 NUKAT|n 2016246185 | ||
| 996 | ‡2 ISNI|0000000496016436 | ||
| 996 | ‡2 LC|n 2019037433 | ||
| 996 | ‡2 LC|n 92107826 | ||
| 996 | ‡2 DNB|1274473233 | ||
| 996 | ‡2 ISNI|0000000064098132 | ||
| 996 | ‡2 NTA|340412437 | ||
| 996 | ‡2 ISNI|0000000388284740 | ||
| 996 | ‡2 LC|n 2004101983 | ||
| 996 | ‡2 BIBSYS|7064331 | ||
| 996 | ‡2 DNB|1105412067 | ||
| 996 | ‡2 RERO|A018080334 | ||
| 996 | ‡2 NSK|000526804 | ||
| 996 | ‡2 PLWABN|9811552473905606 | ||
| 996 | ‡2 ISNI|0000000028390443 | ||
| 996 | ‡2 LC|no2010139920 | ||
| 996 | ‡2 LC|no2019071873 | ||
| 996 | ‡2 ISNI|0000000500423350 | ||
| 996 | ‡2 CAOONL|ncf11530748 | ||
| 996 | ‡2 LC|nr 93046248 | ||
| 996 | ‡2 J9U|987007364593605171 | ||
| 996 | ‡2 NTA|364154683 | ||
| 996 | ‡2 DNB|1243209879 | ||
| 996 | ‡2 NTA|364154152 | ||
| 996 | ‡2 ISNI|0000000069723267 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
